组织地域性

CEVHAP专家成员来自多个国家及地区,包括:澳大利亚,孟加拉国,中国大陆,香港,印度,印度尼西亚,日本,韩国,马来西亚,新西兰,巴基斯坦,菲律宾,新加坡,泰国,越南及中华民国(台湾)。

此外,CEVHAP亦包括数字欧美及非洲专家成员,吾等热忱欢迎并期待所有致力于亚太区病毒性肝炎防治之仝人加入。

FaLang translation system by Faboba

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU

CAF badge

CEVHAP has been vetted and approved to receive tax-deductible donations and grants via CAF America.

If you are a US donor wishing to make a tax-deductible contribution to support us, please visit the “Give Now” page at CAF America’s website at www.cafamerica.org and following these steps:

1. Visit https://cafamerica.org

2. Click “Give Now”

3. “Give a single gift”

4. “Search and Give to organizations in the CAF America Database”

5. Type in “CEVHAP”

6. Click “Donate Now”

7. Fill out the form accordingly and click Submit

8. Enter credit card information and click Submit

9. Wait for the confirmation page – do not re-click submit or refresh the page as you may be additionally charged.

10. An e-mail confirmation will be sent to you for tax deduction purposes.

 

CEVHAP Activity Report Brochure EMAIL smaller Cover

>> 基本概况
病毒性肝炎
全球约有20亿乙肝病毒(HBV)携带者。
由该病毒所致之急性或慢性肝病,平均每
年夺取约60万人生命
如果未经有效治疗,患慢性丙肝及其他
进展性肝病(如肝硬化)之患者比例至2015
年将大幅提升百分之三十八。
目前并无丙肝预防疫苗问世,但约80%
患者可经有效针对性治疗而获痊愈
>> 视频录影资料
病毒性肝炎所致之全球性健康危害

CEVHAP主席陈定信教授

Connect with usconnect with CEVHAP